Work in progress - new look and feel RIVM website As of today, the RIVM website looks different than you are used to. This is because we are now using a new content management system and have implemented an enhanced design.
New data on antimicrobial resistance in European countries New data on antimicrobial resistance (AMR) in European countries is now available in the fourth annual report of the Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAE
Framework Agreement signed between INERIS and RIVM to strengthen cooperation On 7 November 2018, Raymond Cointe, Director-General of INERIS and Hans Brug, Director-General of RIVM, signed a Framework Agreement. RIVM has been working with the French National Institute f
Public Health Foresight study 2018 now available in English The prospects for future public health in the Netherlands are good. Our life expectancy is steadily increasing, and most people feel healthy and do not experience activity limitations.
Coen van Gool named co-chair of WHO Family Development Committee Coen van Gool was named co-chair of the Family Development Committee (FDC) at the Annual Meeting 2018 of the WHO Family of International Classifications (WHO-FIC) Network in Seoul.
Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.